Related Experiment Video
Updated: May 21, 2026
09:34
An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
Published on: August 16, 2021
Immunotherapy for tuberculosis: what's the better choice?
1Department of Respiratory and Critical Care Medicine, the First Affiliated Hospital, Chongqing Medical University, China. guosl999@yeah.net
Frontiers in Bioscience (Landmark Edition)
|June 2, 2012
Summary
Tuberculosis (TB) immunotherapy aims to rebalance immune responses by enhancing Th1 and suppressing Th2 cells. While promising, further research is needed to optimize treatments and minimize potential harm.
Area of Science:
- Immunology
- Infectious Diseases
- Medical Research
Background:
- Tuberculosis (TB) pathogenesis is linked to a Th1/Th2 immune imbalance, characterized by reduced Th1 and elevated Th2 responses.
- Protective immunity against TB involves bacteriostatic and bactericidal mechanisms, yet immunoprotection and pathology coexist in patients.
- Current TB immunotherapy strategies focus on restoring the Th1/Th2 balance to improve treatment outcomes.
Purpose of the Study:
- To review the role of Th1/Th2 imbalance in TB pathogenesis.
- To categorize and discuss current immunotherapy approaches for TB.
- To highlight novel strategies and challenges in TB immunotherapy.
Main Methods:
- Literature review of TB pathogenesis and immunotherapy.
- Classification of immunotherapies into immune-enhancing, immunosuppressive, and immunomodulatory categories.
- Discussion of specific immunomodulatory therapies including cytokine and antibody regulation, vaccines, and hormones.
Main Results:
- A Th1/Th2 imbalance significantly influences TB development and progression.
- Immunotherapy offers potential for TB treatment by modulating immune responses.
- Novel approaches aim to simultaneously up-regulate Th1 and down-regulate Th2 responses.
Conclusions:
- Restoring the Th1/Th2 balance is a key goal in TB immunotherapy.
- Immunomodulatory therapies show promise but require further investigation.
- Optimizing immunotherapy is crucial to maximize benefits and mitigate risks of immunopathological injury.
Related Concept Videos
01:28Pulmonary Tuberculosis V
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
01:26Pulmonary Tuberculosis IV
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
01:29Pulmonary Tuberculosis I
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
01:31Pulmonary Tuberculosis III
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
01:30Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...